7th International Conference on 3D Dosimetry

Den 7. internationale konference om 3D dosimetri afholdes d. 4.-8. november 2012 i Sydney:

http://ic3ddose.org/

Der er stadig åbent for tilmelding. Blandt foredrag kan nævnes:

3D and 4D dosimetry

Vladimir Feygelmann, Moffit Cancer Centre, US: Challenges in 3D dosimetry and the limitations of 2D dosimetry

Stine Korreman, Roskilde Univ, Denmark: The clinical need for 3D dosimetry and practical aspects of the use of current 3D systems in the clinic

Paul Keall, University of Sydney, Australia: Dosimetry requirements for 4D radiotherapy

Tomas Kron. Peter MacCallum Cancer Centre, Australia: Dosimetry requirements for audit and clinical trials

John Schreiner, SE Ontario Cancer Centre, Canada: Analysis/evaluation of 3D distributions, practical issues with gamma and chi comparisons.

Jonathan Sykes, Leeds/St James' Institute of Oncology, UK : Dosimetry of CBCT; methods, doses and clinical consequences

David Thwaites, University of Sydney, Australia: Accuracy required and achievable in radiotherapy dosimetry

Gel dosimetry

Fundamentals: Kim McAuley, Queens Univ, Kingston, Canada

Accuracy and precision: Yves de Deene, University of Ghent, Belgium:

Practical use: Mark Oldham, Duke University, US

Evaluation methods (Yves de Deene, MRI; Simon Doran, Institute of Cancer Research, Sutton, UK, optical; Andrew Jirasek, Univ. of Victoria, Canada, CT)

Other developmental and clinical 3D dosimetry systems

Luc Beaulieu, CHUQ, Canada: Scintillation dosimetry methods

Peter Greer, Univ of Newcastle, Australia: 3D EPID based dosimetry for pre-treatment VMAT verification

Kevin Jordan, Univ of Western Ontario, Canada: Radiochromic and other novel 3D systems

Boyd McCurdy, Cancer-care Manitoba, Canada: Dosimetry using EPIDs; systems, methods, applications

Ben Mijnheer, NKI, The Netherlands: 3D in vivo dosimetry of IMRT and VMAT using EPIDs

Anatoly Rosenfeld/Peter Metcalfe, University of Wollongong, Australia: Developments in solid state dosimetry